These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18207161)

  • 21. Monitored whole gene in vitro evolution of an anti-hRaf-1 affibody molecule towards increased binding affinity.
    Grimm S; Salahshour S; Nygren PÅ
    N Biotechnol; 2012 Jun; 29(5):534-42. PubMed ID: 22027369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Affibody-mediated retention of the epidermal growth factor receptor in the secretory compartments leads to inhibition of phosphorylation in the kinase domain.
    Vernet E; Lundberg E; Friedman M; Rigamonti N; Klausing S; Nygren PA; Gräslund T
    N Biotechnol; 2009 Sep; 25(6):417-23. PubMed ID: 19552886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selection and characterization of an internalizing epidermal-growth-factor-receptor antibody.
    Zhao X; Dai W; Cao L; Zhu H; Yu Y; Ye Q; Wang M; Dai W; Lei P; Shen G
    Biotechnol Appl Biochem; 2007 Jan; 46(Pt 1):27-33. PubMed ID: 16886908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthetic affibody molecules: a novel class of affinity ligands for molecular imaging of HER2-expressing malignant tumors.
    Orlova A; Tolmachev V; Pehrson R; Lindborg M; Tran T; Sandström M; Nilsson FY; Wennborg A; Abrahmsén L; Feldwisch J
    Cancer Res; 2007 Mar; 67(5):2178-86. PubMed ID: 17332348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A truncated soluble epidermal growth factor receptor-Fc fusion ligand trap displays anti-tumour activity in vivo.
    Adams TE; Koziolek EJ; Hoyne PH; Bentley JD; Lu L; Lovrecz G; Ward CW; Lee FT; Scott AM; Nash AD; Rothacker J; Nice EC; Burgess AW; Johns TG
    Growth Factors; 2009 Jun; 27(3):141-54. PubMed ID: 19333814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of intracellular domain of epidermal growth factor receptor and generation of its monoclonal antibody.
    Lin Y; Liu Z; Jiang J; Jiang Z; Ji Y; Sun B
    Cell Mol Immunol; 2004 Apr; 1(2):137-41. PubMed ID: 16212901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of Affibody ligands binding interleukin-2 receptor alpha/CD25.
    Grönwall C; Snelders E; Palm AJ; Eriksson F; Herne N; Ståhl S
    Biotechnol Appl Biochem; 2008 Jun; 50(Pt 2):97-112. PubMed ID: 18284375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-EGFR activation, anti-proliferative and pro-apoptotic effects of polyclonal antibodies induced by EGFR-based cancer vaccine.
    Ramírez BS; Alpízar YA; Fernández DR; Hidalgo GG; Capote AR; Rodríguez RP; Fernández LE
    Vaccine; 2008 Sep; 26(38):4918-26. PubMed ID: 18672015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of lysine-containing mercaptoacetyl-based chelators on the biodistribution of 99mTc-labeled anti-HER2 Affibody molecules.
    Tran TA; Ekblad T; Orlova A; Sandström M; Feldwisch J; Wennborg A; Abrahmsén L; Tolmachev V; Eriksson Karlström A
    Bioconjug Chem; 2008 Dec; 19(12):2568-76. PubMed ID: 19035668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feasibility of imaging of epidermal growth factor receptor expression with ZEGFR:2377 affibody molecule labeled with 99mTc using a peptide-based cysteine-containing chelator.
    Andersson KG; Oroujeni M; Garousi J; Mitran B; Ståhl S; Orlova A; Löfblom J; Tolmachev V
    Int J Oncol; 2016 Dec; 49(6):2285-2293. PubMed ID: 27748899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular studies of binding, internalization and retention of a radiolabeled EGFR-binding affibody molecule.
    Nordberg E; Friedman M; Göstring L; Adams GP; Brismar H; Nilsson FY; Ståhl S; Glimelius B; Carlsson J
    Nucl Med Biol; 2007 Aug; 34(6):609-18. PubMed ID: 17707800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved tumor-to-organ ratios of a novel 67Ga-human epidermal growth factor radionuclide conjugate with preadministered antiepidermal growth factor receptor affibody molecules.
    Sandström K; Haylock AK; Velikyan I; Spiegelberg D; Kareem H; Tolmachev V; Lundqvist H; Nestor M
    Cancer Biother Radiopharm; 2011 Oct; 26(5):593-601. PubMed ID: 21834651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Three-dimensional histologic validation of high-resolution SPECT of antibody distributions within xenografts.
    Branderhorst W; Blezer EL; Houtkamp M; Ramakers RM; van den Brakel JH; Witteveen H; van der Have F; Gratama van Andel HA; Vastenhouw B; Wu C; Walsum MS; van Dongen GA; Viergever MA; Bleeker WK; Beekman FJ
    J Nucl Med; 2014 May; 55(5):830-7. PubMed ID: 24686779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved mutants from directed evolution are biased to orthologous substitutions.
    Cochran JR; Kim YS; Lippow SM; Rao B; Wittrup KD
    Protein Eng Des Sel; 2006 Jun; 19(6):245-53. PubMed ID: 16740523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation and evaluation of bispecific affibody molecules for simultaneous targeting of EGFR and HER2.
    Ekerljung L; Wållberg H; Sohrabian A; Andersson K; Friedman M; Frejd FY; Ståhl S; Gedda L
    Bioconjug Chem; 2012 Sep; 23(9):1802-11. PubMed ID: 22882002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of novel 68Ga- and 18F-labeled GnRH-I analogues with high GnRHR-targeting efficiency.
    Schottelius M; Berger S; Poethko T; Schwaiger M; Wester HJ
    Bioconjug Chem; 2008 Jun; 19(6):1256-68. PubMed ID: 18510351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced activation of epidermal growth factor receptor caused by tumor-derived E-cadherin mutations.
    Bremm A; Walch A; Fuchs M; Mages J; Duyster J; Keller G; Hermannstädter C; Becker KF; Rauser S; Langer R; von Weyhern CH; Höfler H; Luber B
    Cancer Res; 2008 Feb; 68(3):707-14. PubMed ID: 18245470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor targeting using affibody molecules: interplay of affinity, target expression level, and binding site composition.
    Tolmachev V; Tran TA; Rosik D; Sjöberg A; Abrahmsén L; Orlova A
    J Nucl Med; 2012 Jun; 53(6):953-60. PubMed ID: 22586147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficient selection of DARPins with sub-nanomolar affinities using SRP phage display.
    Steiner D; Forrer P; Plückthun A
    J Mol Biol; 2008 Oct; 382(5):1211-27. PubMed ID: 18706916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Humoral immunity responses against EGFR-positive tumor cells induced by xenogeneic EGFR expressed in the yeast Pichia pastoris.
    Fang F; Chen P; Chen XC; Li J; Wen YJ; Wei YQ
    Int J Mol Med; 2009 Feb; 23(2):181-8. PubMed ID: 19148541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.